The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1141876831 11418768 31 F 20150813 20160721 20150826 20160725 EXP CN-009507513-1508CHN010667 MERCK 68.00 YR M Y 66.00000 KG 20160725 MD CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1141876831 11418768 1 PS EMEND APREPITANT 1 Oral 125 MG, ONCE (DAY 1) Y1250 21549 125 MG CAPSULE 1X
1141876831 11418768 2 SS EMEND APREPITANT 1 Oral 80 MG, QD (DAY 2) Y1250 21549 80 MG CAPSULE QD
1141876831 11418768 3 SS EMEND APREPITANT 1 Oral 80 MG, QD (DAY 3) Y1250 21549 80 MG CAPSULE QD
1141876831 11418768 4 C DOCETAXEL. DOCETAXEL 1 Intravenous drip 100 MG, TREATMENT REGIMEN: DP, TREATMENT CYCLE: 1/UNK U 0 100 MG INJECTION
1141876831 11418768 5 C CISPLATIN. CISPLATIN 1 Intravenous drip 120 MG, TREATMENT REGIMEN: DP, TREATMENT CYCLE: 1/UNK U 0 120 MG INJECTION
1141876831 11418768 6 C PALONOSETRON HYDROCHLORIDE. PALONOSETRON HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0.25 MG, QD U 0 .25 MG INJECTION QD
1141876831 11418768 7 C DEXAMETHASONE. DEXAMETHASONE 1 Intravenous (not otherwise specified) 6 MG, QD U 0 6 MG INJECTION QD
1141876831 11418768 8 C GLUTATHIONE GLUTATHIONE 1 Intravenous drip 1200 MG, QD U 0 INJECTION QD
1141876831 11418768 9 C GLUTATHIONE GLUTATHIONE 1 Intravenous (not otherwise specified) 1200 MG, QD U 0 INJECTION QD
1141876831 11418768 10 C Polyene Phosphatidyl choline 2 Oral 1368 MG DAILY, TID 4104 MG U 0 CAPSULE TID
1141876831 11418768 11 C XIAOAIPING 2 Intravenous drip TOTAL DAILY DOSE: 60 ML/CC, QD 420 ML U 0 60 ML INJECTION QD
1141876831 11418768 12 C XIAOAIPING 2 Intravenous drip 60 ML/CC, QD 420 ML U 0 60 ML INJECTION QD
1141876831 11418768 13 C AMIFOSTINE. AMIFOSTINE 1 Intravenous drip 400 MG, QD 1200 MG U 0 400 MG INJECTION QD
1141876831 11418768 14 C AMIFOSTINE. AMIFOSTINE 1 Intravenous drip 400 MG, QD 1200 MG U 0 400 MG INJECTION QD
1141876831 11418768 15 C FUROSEMIDE. FUROSEMIDE 1 Oral 20 MG, QD (ALSO REPORTED AS INJECTION) 60 MG U 0 20 MG TABLET QD
1141876831 11418768 16 C DEXAMETHASONE. DEXAMETHASONE 1 Oral TOTAL DAILY DOSE: 3.75MG, FREQUENCY: BID U 0 TABLET BID
1141876831 11418768 17 C ESTAZOLAM. ESTAZOLAM 1 Oral 2 MG, HS (QN) 14 MG U 0 2 MG TABLET QD
1141876831 11418768 18 C ESTAZOLAM. ESTAZOLAM 1 14 MG U 0 TABLET
1141876831 11418768 19 C LANSOPRAZOLE. LANSOPRAZOLE 1 Intravenous drip 30 MG, QD 90 MG 0 30 MG INJECTION QD
1141876831 11418768 20 C METOCLOPRAMIDE HYDROCHLORIDE. METOCLOPRAMIDE HYDROCHLORIDE 1 Intramuscular 10 MG, QD 30 MG 0 10 MG QD
1141876831 11418768 21 C AMINO ACIDS (UNSPECIFIED) AMINO ACIDS 1 Intravenous drip 50 G, QD 100 G 0 50 G QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1141876831 11418768 1 Prophylaxis of nausea and vomiting
1141876831 11418768 4 Chemotherapy
1141876831 11418768 5 Chemotherapy
1141876831 11418768 6 Prophylaxis of nausea and vomiting
1141876831 11418768 7 Prophylaxis of nausea and vomiting
1141876831 11418768 8 Prophylaxis
1141876831 11418768 10 Prophylaxis
1141876831 11418768 11 Neoplasm malignant
1141876831 11418768 13 Prophylaxis
1141876831 11418768 14 Prophylaxis of nausea and vomiting
1141876831 11418768 15 Diuretic therapy
1141876831 11418768 16 Prophylaxis of nausea and vomiting
1141876831 11418768 17 Sedative therapy
1141876831 11418768 18 Sleep disorder
1141876831 11418768 19 Prophylaxis
1141876831 11418768 20 Prophylaxis of nausea and vomiting
1141876831 11418768 21 Protein deficiency

Outcome of event

Event ID CASEID OUTC COD
1141876831 11418768 HO
1141876831 11418768 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1141876831 11418768 Alanine aminotransferase increased
1141876831 11418768 Aspartate aminotransferase increased
1141876831 11418768 Blood potassium decreased
1141876831 11418768 Bone marrow failure
1141876831 11418768 Cough
1141876831 11418768 Decreased appetite
1141876831 11418768 Nausea
1141876831 11418768 Productive cough
1141876831 11418768 Pyrexia
1141876831 11418768 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1141876831 11418768 1 20150813 20150813 0
1141876831 11418768 2 20150814 20150814 0
1141876831 11418768 3 20150815 20150815 0
1141876831 11418768 4 20150813 20150813 0
1141876831 11418768 5 20150813 20150813 0
1141876831 11418768 6 20150813 20150813 0
1141876831 11418768 7 20150813 20150813 0
1141876831 11418768 8 20150808 20150812 0
1141876831 11418768 9 20150813 20150815 0
1141876831 11418768 10 20150807 20150812 0
1141876831 11418768 11 20150807 20150812 0
1141876831 11418768 12 20150817 20150817 0
1141876831 11418768 13 20150810 20150812 0
1141876831 11418768 14 20150819 20150824 0
1141876831 11418768 15 20150810 20150812 0
1141876831 11418768 16 20150812 20150812 0
1141876831 11418768 17 20150813 20150823 0
1141876831 11418768 19 20150813 20150815 0
1141876831 11418768 20 20150813 20150815 0
1141876831 11418768 21 20150813 20150814 0